Product Categories
| Country: | China |
|---|---|
| Tel: | 21-61263452 |
| Mobile: | 13641803416 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Company Name: | Shanghai GL Peptide Ltd |
| Tel: | 86-21-61263385 |
| Fax: | 86-21-61263399 |
| Email: | ymbetter@glbiochem |
| WebSite: | http://www.glbiochem.com |
| Nationality: | CHINA |
| Product Name | MF | CAS | Details |
|---|
| Histine-Rich Basic Peptide (HRBP)(Aplysia californica) | Details |
| Histone H1-derived peptide??;GGGPATPKKAKKL | Details |
| Histone H3 (1-25),amide,??;ARTKQTARKSTGGKAPRKQLATKAA-NH2 | Details |
| Histone H3 (116–136), N15–39??;APRKQLATKAARKSAPATGGVKKPH | Details |
| HIV: gp120: 318-327 | C48H80N16O12 | 147841-68-7 | Details |
| HIV Peptide gp120 (254-274) | C95H162N28O30S | 113944-46-0 | Details |
| HIV (gp120) Antigenic Peptide | C117H211N41O31S | 198636-94-1 | Details |
| HIV Substrate;KARVNleF(4-NO2)EANle-NH2 | C49H83N15O13 | 128340-47-6 | Details |
| HIV QK10??;QVPLRMTYK | Details |
| HIV-1 env Protein gp120 (278-292) (strains BH10, BH8, HXB2, HXB3, PV22) | C73H126N26O18 | 114991-28-5 | Details |
| HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) | Details |
| HIV-1 gag Protein p24 (137-154) | C92H158N26O26S | Details |
| HIV-1 gag Protein p24 (194-210) | C73H126N20O23S | 141281-67-6 | Details |
| HIV-1 gag Protein p24 (65-73) (isolates MAL/U455) | C44H79N11O14S2 | 334731-59-8 | Details |
| HIV-1 Tat (49-57) N-term Cys | Details |
| HIV-1 tat Protein (49-57) | C53H106N30O11 | 123251-89-8 | Details |
| HIV-1, HIV-2 Protease Substrate;ATLNFPISPW | C56H80N12O14 | Details |
| HIV (gp120) Fragment (308-331) | C114H199N41O31 | 115416-08-5 | Details |
| HIV (gp41) Antigenic Peptide 5 | Details |
| HIV (gp41) Fragment | C21H38N6O7 | 129426-47-7 | Details |
| HLA-DQA1 (62 to 77) | Details |
| HOE 140 | C59H89N19O13S | 130308-48-4 | Details |
| HPV-E6-N | Details |
| Human CMV Assemblin Protease Substrate (M-site) | C52H96N20O16 | Details |
| CEF20, Cytomegalovirus, CMV pp65 (495-503);NLVPMVATV | C42H74N10O12S | 153045-21-7 | Details |
| Human Papillomavirus E7 protein (49-57);RAHYNIVTF | C52H77N15O13 | Details |
| Hypercalcemia Malignancy Factor (1-34), amide, human | C180H288N58O47 | 112955-31-4 | Details |
| Hydrin 2 | C45H69N15O14S2 | 122842-55-1 | Details |
| Hylambatin | C63H90N16O19S2 | 80890-46-6 | Details |
| Hypercalcemia Malignancy Factor (1-34), (PLP) human;AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | C180H287N57O48 | 112540-82-6 | Details |
| Hypercalcemia Malignancy Factor (1-40);AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIRATS | C207H334N66O58 | 120298-73-9 | Details |
| Hypocretin (70-98) (human) | C125H214N44O37S | 1129545-33-0 | Details |
| ICE Inhibitor III | Details |
| ig Endothelin-3: 1-41, amide, rat | Details |
| IL-8 (-5 to +5) | C48H86N14O14 | Details |
| IL-8 Inhibitor | C45H66N18O7S | 138559-60-1 | Details |
| IL-8ra (9-29) | C112H150N24O38S2 | 188689-66-9 | Details |
| Influenza A NP (366-374)??;ASNEMNDAM | C36H59N11O17S2 | Details |
| Insulin-Like Growth Factor I (30-41) | C51H83N19O19 | 82177-09-1 | Details |
| IGF-I Analog | C55H88N14O15S2 | 147819-32-7 | Details |
| IL-1 b Converting Enzyme: ICE Substrate II | Details |
| H-D-Ala-Gln-octadecyl ester · HCl | C18H36ClN3O4 | 153508-74-8 | Details |
| H-D-Ala-Gln-OH | C8H15N3O4 | 205252-36-4 | Details |
| H-D-Ala-Gly-OH | C5H10N2O3 | 3997-90-8 | Details |
| H-D-Ala-Leu-Lys-AMC | C25H37N5O5 | 104881-72-3 | Details |
| H-D-Ala-Phe-OH | C12H16N2O3 | 3061-95-8 | Details |
| H-D-Ala-Pro-OH | C8H14N2O3 | 61430-12-4 | Details |
| H-D-Arg-Gly-Asp-Trp-OH | C23H32N8O7 | Details |
| H-D-Arg-Phe-OH | C15H23N5O3 | 133410-92-1 | Details |
| H-D-Glu(Gly-OH)-OH | C7H12N2O5 | 6729-55-1 | Details |
| H-D-Glu-D-Glu-OH | C10H16N2O7 | 6729-94-8 | Details |
| H-D-Ile-Phe-Lys-pNA | C27H38N6O5 | 76626-41-0 | Details |
| H-DL-Ala-DL-Ala-OH | C6H12N2O3 | 2867-20-1 | Details |
| H-DL-Ala-DL-Leu-Gly-OH | C11H21N3O4 | 82267-71-8 | Details |
| H-DL-Ala-DL-Leu-OH | C9H18N2O3 | 1999-42-4 | Details |
| H-DL-Ala-DL-Phe-OH | C12H16N2O3 | 1999-45-7 | Details |
| H-DL-Ala-DL-Val-OH | C8H16N2O3 | 1999-46-8 | Details |
| H-DL-Ala-Gly-Gly-OH | C7H13N3O4 | 927-21-9 | Details |
| H-DL-Ala-Gly-OH | C5H10N2O3 | 1188-01-8 | Details |
| H-D-Leu-Gly-Gly-OH | C10H19N3O4 | 18625-22-4 | Details |
| H-D-Leu-Gly-OH | C8H16N2O3 | 997-05-7 | Details |
| H-D-Leu-Thr-Arg-pNA | C22H36N8O6 | 122630-72-2 | Details |
| H-D-Leu-Tyr-OH | C15H22N2O4 | 3303-29-5 | Details |
| H-D-Phg-Leu-OH | C14H20N2O3 | 110207-44-8 | Details |
| H-D-Pro-Phe-Arg-pNA · 2 HCl | C26H36Cl2N8O5 | 62354-56-7 | Details |
| Head Activator;Pyr-PPGGSKVILF | C54H84N12O14 | Details |
| Hemoglobin (Hb) (64-76);GKKVITAFNEGLK | C64H109N17O18 | Details |
| Hemokinin 1 (mouse, rat) | C61H100N22O15S | 208041-90-1 | Details |
| Hepatitis A Virus (HAV) 3C Protease Substrate | C65H87N17O16S | 145682-87-7 | Details |
| Hepatitis Virus C NS3 Protease Inhibitor 1 | Details |
| Hepcidin-25 (human) | C113H178N34O31S9 | 342790-21-0 | Details |
| Hirudin (54-65) (desulfated) | C66H93N13O25 | 113274-56-9 | Details |
| Histatin-3 (H3);DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN | Details |
| Histatin-5;DSHAKRHHGYKRKFHEKHHSHRGY | C133H195N51O33 | 104339-66-4 | Details |
| H-DL-Leu-DL-Ala-OH | C9H18N2O3 | 5060-46-8 | Details |
| H-DL-Leu-DL-Phe-OH | C15H22N2O3 | 56217-82-4 | Details |
| H-DL-Leu-DL-Tyr-OH | C15H22N2O4 | 19659-00-8 | Details |
| H-DL-Leu-Gly-DL-Phe-OH | C17H25N3O4 | 4294-25-1 | Details |
| H-DL-Leu-Gly-OH | C8H16N2O3 | 615-82-7 | Details |
| H-DL-Val-Leu-Arg-pNA | C23H38N8O5 | 117961-22-5 | Details |
| H-D-Met-D-Met-OH | C10H20N2O3S2 | 89680-20-6 | Details |
| H-D-Met-Met-OH | C10H20N2O3S2 | 89680-17-1 | Details |
| H-D-Phe-Ala-OH | C12H16N2O3 | 80924-58-9 | Details |
| H-D-Phe-D-Phe-OH | C18H20N2O3 | 58607-69-5 | Details |
| H-D-Phe-Homopro-Arg-pNA · 2 acetate | C31H44N8O9 | 386253-60-7 | Details |
| H-D-Phe-Pro-Arg-5-amido-isophthalic acid-dimethyl ester | Details |
| H-D-Phe-Pro-Arg-chloromethylketone | C21H31ClN6O3 | 71142-71-7 | Details |
| H-D-Phe-Pro-OH | C14H18N2O3 | 51926-52-4 | Details |
| H-D-Phe-Ser(Bzl)-Phe-OH | C28H31N3O5 | Details |
| H-D-Phe-Ser(Bzl)-Phe-Phe-Ala-Ala-4-Abz-OH | C53H60N8O10 | Details |
| H-DL-Leu-Gly-Gly-OH | C10H19N3O4 | 4337-37-5 | Details |
| H-D-Trp-D-Met-p-chloro-D-Phe-Gla-NH2 | C31H37ClN6O8S | 178396-45-7 | Details |
| H-D-Leu-Leu-OH | C12H24N2O3 | 38689-31-5 | Details |
| H-D-Leu-D-Leu-OH | C12H24N2O3 | 38689-30-4 | Details |
| H-DL-Ala-DL-Met-OH | C8H16N2O3S | 1999-43-5 | Details |
| H-D-Ile-Asp-OH | C10H18N2O5 | 120067-35-8 | Details |
| H-Glu(Trp-OH)-OH | C16H19N3O5 | 66471-20-3 | Details |
| H-D-Ala-Gly-Gly-OH | C7H13N3O4 | 77286-90-9 | Details |
| Hydrin 1' | C51H81N17O15S2 | 148440-73-7 | Details |
| H-D-Met-Met-Met-OH | C15H29N3O4S3 | 319927-24-7 | Details |
| Product Total： Product Page： | ||||
| 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 | ||||